1opl: Difference between revisions

Line 4:

==Overview==

c-Abl is normally regulated by an autoinhibitory mechanism, the disruption, of which leads to chronic myelogenous leukemia. The details of this, mechanism have been elusive because c-Abl lacks a phosphotyrosine residue, that triggers the assembly of the autoinhibited form of the closely, related Src kinases by internally engaging the SH2 domain. Crystal, structures of c-Abl show that the N-terminal myristoyl modification of, c-Abl 1b binds to the kinase domain and induces conformational changes, that allow the SH2 and SH3 domains to dock onto it. Autoinhibited c-Abl, forms an assembly that is strikingly similar to that of inactive Src, kinases but with specific differences that explain the differential, ability of the drug STI-571/Gleevec/imatinib (STI-571) to inhibit the, catalytic activity of Abl, but not that of c-Src.

c-Abl is normally regulated by an autoinhibitory mechanism, the disruption of which leads to chronic myelogenous leukemia. The details of this mechanism have been elusive because c-Abl lacks a phosphotyrosine residue that triggers the assembly of the autoinhibited form of the closely related Src kinases by internally engaging the SH2 domain. Crystal structures of c-Abl show that the N-terminal myristoyl modification of c-Abl 1b binds to the kinase domain and induces conformational changes that allow the SH2 and SH3 domains to dock onto it. Autoinhibited c-Abl forms an assembly that is strikingly similar to that of inactive Src kinases but with specific differences that explain the differential ability of the drug STI-571/Gleevec/imatinib (STI-571) to inhibit the catalytic activity of Abl, but not that of c-Src.

==Disease==

Line 26:

[[Category: Superti-Furga, G.]]

[[Category: Veach, D.]]

[[Category: Young, M.A.]]

[[Category: Young, M A.]]

[[Category: MYR]]

[[Category: P16]]

[[Category: transferase]]

''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on ~~Fri~~ Feb ~~15 16~~:35:02 2008''

''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:20:13 2008''

Navigation menu

Page actions

Page actions

Personal tools

Navigation

Search

Tools

@@ Line 4: / Line 4: @@
 ==Overview==
-c-Abl is normally regulated by an autoinhibitory mechanism, the disruption, of which leads to chronic myelogenous leukemia. The details of this, mechanism have been elusive because c-Abl lacks a phosphotyrosine residue, that triggers the assembly of the autoinhibited form of the closely, related Src kinases by internally engaging the SH2 domain. Crystal, structures of c-Abl show that the N-terminal myristoyl modification of, c-Abl 1b binds to the kinase domain and induces conformational changes, that allow the SH2 and SH3 domains to dock onto it. Autoinhibited c-Abl, forms an assembly that is strikingly similar to that of inactive Src, kinases but with specific differences that explain the differential, ability of the drug STI-571/Gleevec/imatinib (STI-571) to inhibit the, catalytic activity of Abl, but not that of c-Src.
+c-Abl is normally regulated by an autoinhibitory mechanism, the disruption of which leads to chronic myelogenous leukemia. The details of this mechanism have been elusive because c-Abl lacks a phosphotyrosine residue that triggers the assembly of the autoinhibited form of the closely related Src kinases by internally engaging the SH2 domain. Crystal structures of c-Abl show that the N-terminal myristoyl modification of c-Abl 1b binds to the kinase domain and induces conformational changes that allow the SH2 and SH3 domains to dock onto it. Autoinhibited c-Abl forms an assembly that is strikingly similar to that of inactive Src kinases but with specific differences that explain the differential ability of the drug STI-571/Gleevec/imatinib (STI-571) to inhibit the catalytic activity of Abl, but not that of c-Src.
 ==Disease==
@@ Line 26: / Line 26: @@
 [[Category: Superti-Furga, G.]]
 [[Category: Veach, D.]]
-[[Category: Young, M.A.]]
+[[Category: Young, M A.]]
 [[Category: MYR]]
 [[Category: P16]]
 [[Category: transferase]]
-''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 16:35:02 2008''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:20:13 2008''